Health Care Reform Is Personal for Wisconsin Congresswoman in Remission for Cancer
*By Justin Chermol*
For veteran congresswoman and cancer survivor Gwen Moore of Wisconsin, the issue of healthcare is both political and personal.
The lawmaker, who just entered remission after 10 months battling small-cell lymphoma, knows she's among the lucky ones. She did not have to battle an insurance company over a pre-existing condition or cope with in spike in her premiums.
In President Trump's second State of the Union speech, he set health care as priority and vowed "to protect patients with pre-existing conditions."
But according to Moore, that promise is empty.
"Despite the rhetoric of Republicans, it's just rhetorical on their part when they say 'Oh, we want to protect people with pre-existing conditions.' No, you can't do it if you in fact repeal the Affordable Care Act," she said.
"I think one of the centerpieces of the Affordable Care Act is that we required insurance companies to provide real plans, not these junk plans, " she added of the Obama-era law that was thrown into question when President Trump took office.
Meanwhile, drug prices continue to surge.
Americans spend nearly $1,200 on prescription drugs a year, according to the [OECD](https://data.oecd.org/healthres/pharmaceutical-spending.htm).
"It is absolutely foolish that the government has one of the biggest pools of customers in the country ー consumers of health care, when you consider Medicaid and Medicare ー and yet we don't require pharmaceutical companies to negotiate their prices.
"It's a totally anti-capitalist notion," Moore continued. "For people who say they are against socialism ー and therefore \[prefer\] the market figuring it out ー one of the things the market would do, is have you negotiate across this huge pool of consumers."
"That's very low hanging fruit."
For full interview [click here](https://cheddar.com/videos/rep-gwen-moore-d-wi-aims-to-protect-taxpayers-with-new-legislation).
Sabrina Siddiqui, National Politics Reporter at The Wall Street Journal, joins to break down the SNAP funding delays and the human cost of the ongoing shutdown.
Arguments at the Supreme Court have concluded for the day as the justices consider President Donald Trump's sweeping unilateral tariffs in a trillion-dollar test of executive power.
President Donald Trump said he has decided to lower his combined tariff rates on imports of Chinese goods to 47% after talks with Chinese leader Xi Jinping on curbing fentanyl trafficking.
The Federal Reserve cut its key interest rate Wednesday for a second time this year as it seeks to shore up economic growth and hiring even as inflation stays elevated. The move comes amid a fraught time for the central bank, with hiring sluggish and yet inflation stuck above the Fed’s 2% target. Compounding its challenges, the central bank is navigating without much of the economic data it typically relies on from the government. The Fed has signaled it may reduce its key rate again in December but the data drought raises the uncertainty around its next moves. Fed Chair Jerome Powell told reporters that there were “strongly differing views” at the central bank's policy meeting about to proceed going forward.
U.S. and Chinese officials say a trade deal between the world’s two largest economies is drawing closer. The sides have reached an initial consensus for President Donald Trump and Chinese leader Xi Jinping to aim to finalize during their high-stakes meeting Thursday in South Korea. Any agreement would be a relief to international markets. Trump's treasury secretary says discussions with China yielded preliminary agreements to stop the precursor chemicals for fentanyl from coming into the United States. Scott Bessent also says Beijing would make “substantial” purchases of soybean and other agricultural products while putting off export controls on rare earth elements needed for advanced technologies.
